Financial Gravity Companies’s Amphastar Pharmaceuticals AMPH Stock Holding History

Financial Gravity Companies’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$1K	Buy	+30	New	+$591	﹤0.01%	1011

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Financial Gravity Companies's AMPH Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Amphastar Pharmaceuticals (AMPH) in Q4 2018: 30 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1011 among its holdings.

134 funds tracked by Wall St. Rank hold AMPH as of Q4 2018.

Financial Gravity Companies held 30 shares of Amphastar Pharmaceuticals worth $1K as of Q4 2018.
Amphastar Pharmaceuticals was a new Financial Gravity Companies position in Q4 2018.
Amphastar Pharmaceuticals made up ﹤0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #1011 holding.
134 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.